C-reactive protein-mediated suppression of nephrotoxic nephritis: Role of macrophages, complement, and Fcγ receptors

Journal of Immunology

Volumn 178, Issue 1, 2007, Pages 530-538

  Rodriguez, Wilfredo ^a   Mold, Carolyn ^a   Kataranovski, Milena ^a   Hutt, Julie A ^b   Marnell, Lorraine L ^a   Verbeek, J Sjef ^c   Du Clos, Terry W ^a,d  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; CLODRONIC ACID; COBROTOXIN; COMPLEMENT; FC RECEPTOR; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOSOME; PENTRAXIN;

ACUTE PHASE RESPONSE; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; IMMUNE COMPLEX NEPHRITIS; INFLAMMATION; LIVER; MACROPHAGE; MOUSE; NONHUMAN; ONSET AGE; PERITONEUM CELL; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SURVIVAL;

EID: 33845957100     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.1.530     Document Type: Article

References (44)

1. Volanakis, J. E. 2001. Human C-reactive protein: expression, structure, and function. Mol. Immunol. 38: 189-197.
2. Marnell, L., C. Mold, and T. W. Du Clos. 2005. C-reactive protein: ligands, receptors and role in inflammation. Clin. Immunol. 117: 104-111.
3. Black, S., I. Kushner, and D. Samols. 2004. C-reactive protein. J. Biol. Chem. 279: 48487-48490.
4. Thompson, D., M. B. Pepys, and S. P. Wood. 1999. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7: 169-177.
5. Kaplan, M. H., and J. E. Volanakis. 1974. Interactions of C-reactive protein with the complement system, I: consumption of human complement associated with the reaction of C-reactive protein with pneumococcal polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J. Immunol. 112: 2135-2147.
6. Bharadwaj, D., M. P. Stein, M. Volzer, C. Mold, and T. W. Du Clos. 1999. The major receptor for C-reactive protein on leukocytes is Fcγ receptor II. J. Exp. Med. 190: 585-590.
7. Marnell, L. L., C. Mold, M. A. Volzer, R. W. Burlingame, and T. W. Du Clos. 1995. C-reactive protein binds to FcγRI in transfected COS cells. J. Immunol. 155: 2185-2193.
8. Ahmed, N., R. Thorley, D. Xia, D. Samols, and R. O. Webster. 1996. Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis. Am. J. Resp. Crit. Care Med. 153: 1141-1147.
9. Xia, D., and D. Samols. 1997. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc. Natl. Acad. Sci. USA 94: 2575-2580.
10. Heuertz, R. M., X. Dongyuan, D. Samols, and R. O. Webster. 1994. Inhibition of C5a des Arg-induced neutrophil alveolitis in transgenic mice expressing C-reactive protein. Am. J. Physiol. 266: L649-L654.
11. Heuertz, R. M., S. M. Tricomi, U. R. Ezekieli, and R. O. Webster. 1999. C-reactive protein inhibits chemotactic peptide-induced p38 mitogen-activated protein kinase activity and human neutrophil movement. J. Biol. Chem. 275: 17968-17974.
12. Zhong, S., Q. Zen, J. Tebo, K. Schlottmann, M. Coggeshall, and R. F. Mortensen. 1998. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling. J. Immunol. 161: 2533-2540.
13. Black, S., A. Wilson, and D. Samols. 2005. An intact phosphocholine binding site is necessary for transgenic rabbit C-reactive protein to protect mice against challenge with platelet-activating factor. J. Immunol. 175: 1192-1196.
14. Mold, C., W. Rodriguez, B. Rodic-Polic, and T. W. Du Clos. 2002. C-reactive protein mediates protection from lipopolysaccharide through interactions with FcγR. J. Immunol. 169: 7019-7025.
15. Sutterwala, F. S., G. J. Noel, P. Salgame, and D. M. Mosser. 1998. Reversal of proinflammatory responses by ligating the macrophage Fcγ receptor type I. J. Exp. Med. 188: 217-222.
16. Gerber, J. S., and D. M. Mosser. 2001. Reversing lipopolysaccharide toxicity by ligating the macrophage Fcγ receptors. J. Immunol. 166: 6861-6868.
17. Du Clos, T. W. 1996. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens. Mol. Biol. Rep. 23: 253-260.
18. Mold, C., R. Baca, and T. W. Du Clos. 2002. Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcγ receptors. J. Autoimmun. 19: 147-154.
19. Gershov, D., S. Kim, N. Brot, and K. B. Elkon. 2000. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192: 1353-1363.
20. 1 mice treated with C-reactive protein. Clin. Immunol. Immunopathol. 70: 22-27.
21. 1 mice expressing a human C-reactive protein transgene. Arthritis Rheum. 48: 1602-1611.
22. Rodriguez, W., C. Mold, M. Kataranovski, J. Hutt, L. L. Marnell, and T. W. Du Clos. 2005. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Arthritis Rheum. 52: 642-650.
23. Rodriguez, W., C. Mold, L. L. Marnell, J. Hutt, G. J. Silverman, D. Tran, and T. W. Du Clos. 2006. Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein. Arthritis Rheum. 54: 325-335.
24. Szalai, A. J., S. Nataf, X. Z. Hu, and S. R. Barnum. 2002. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J. Immunol. 168: 5792-5797.
25. Wilson, C. B. 2001. Immune models of glomerular injury. In Immunological Renal Diseases. E. G. Neilson and W. G. Couser, eds. Lippincott, Williams and Wilkins, Philadelphia, pp. 711-777.
26. Ioan-Facsinay, A., S. de Kimpe, S. Hellwig, P. van Lent, F. Hofhuis, H. van Ojik, C. Sedlik, S. da Silveira, J. Gerber, Y. de Jong, et al. 2002. FcγR1 (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16: 391-402.
27. Du Clos, T. W. 1989. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J. Immunol. 143: 2553-2559.
28. Wakayama, H., Y. Hasegawa, T. Kawabe, T. Hara, S. Matsuo, M. Mizuno, T. Takai, H. Kikutani, and K. Shimokata. 2002. Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcR γ-deficient mice. Eur. J. Immunol. 30: 1182-1190.
29. Salant, D. J., and A. V. Cybulsky. 1988. Experimental glomerulonephritis. Methods Enzymol. 162: 421-461.
30. van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93.
31. Du Clos, T. W., M. A. Volzer, F. F. Hahn, R. Xiao, C. Mold, and R. P. Searles. 1999. Chromatin clearance in C57BL/10 mice: interaction with heparan sulphate proteoglycans and receptors on Kupffer cells. Clin. Exp. Immunol. 117: 403-411.
32. Burlingame, R. W., M. A. Volzer, J. Harris, and T. W. Du Clos. 1996. The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice. J. Immunol. 156: 4783-4788.
33. Denny, M. F., P. Chandaroy, P. D. Killen, R. Caricchio, E. E. Lewis, B. C. Richardson, K. D. Lee, J. Gavalchin, and M. J. Kaplan. 2006. Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J. Immunol. 176: 2095-2104.
34. Kitching, A. R., P. G. Tipping, J. R. Timoshanko, and S. R. Holdsworth. 2000. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis. Kidney Int. 57: 518-525.
35. Mold, C., H. Gewurz, and T. W. Du Clos. 1999, Regulation of complement activation by C-reactive protein. Immunopharmacology 42: 23-30.
36. Tipping, P. G., M. G. Lowe, and S. R. Holdsworth. 1991. Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. Kidney Int. 39: 103-110.
37. Timoshanko, J. R., A. R. Kitching, Y. Iwakura, S. R. Holdsworth, and P. G. Tipping. 2004. Leukocyte-derived interleukin-1β interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis. Am. J. Pathol. 164: 1967-1977.
38. Fu, Y., C. Xie, J. Chen, J. Zhu, H. Zhou, J. Thomas, X. J. Zhou, and C. Mohan. 2006. Innate stimuli accentuate end-organ damage by nephrotoxic antibodies via Fc receptor and TLR stimulation and IL-1/TNF-α production. J. Immunol. 176: 632-639.
39. Bruhns, P., A. Samuelsson, J. W. Pollard, and J. V. Ravetch. 2003. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 18: 573-581.
40. Kaneko, Y., F. Nimmerjahn, M. P. Madaio, and J. V. Ravetch. 2006. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J. Exp. Med. 203: 789-797.
41. Siragam, V., A. R. Crow, D. Brine, S. Song, J. Freedman, and A. H. Lazarus. 2006. Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells. Nat. Med. 12: 688-692.
42. Suresh, M. V., S. K. Singh, D. A. Ferguson, Jr., and A. Agrawal. 2006. Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection. J. Immunol. 176: 4369-4374.
43. Berman, S., H. Gewurz, and C. Mold. 1986. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis. J. Immunol. 136: 1354-1359.
44. Zhang, X., J. P. Edwards, and D. M. Mosser. 2006. Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription. J. Immunol. 177: 1282-1288.